Table 2.
Patients characteristics, indications and results of FOB
| No | Diagnosis at hospitalisation | Immuno-suppression | PreFOB ARDS category | FOB indications | FOB diagnosis | Infectious agents | Intubation | Intubation time (hour) |
|---|---|---|---|---|---|---|---|---|
| 1 | Pneumonia | + | Severe | Opportunistic infections | Infection | CMV | - | |
| 2 | Pneumonia | + | Mild | Opportunistic infections | Infection | Geotrichum capitatum | + | 24–48 |
| 3 | Pneumonia | - | Severe | Opportunistic infections | Infection | Aspergillus spp., Respiratory virus | - | |
| 4 | Pneumonia | + | Mild | Opportunistic infections | Infection | C. albicans, CMV, Respiratory virus | - | |
| 5 | Pneumonia | + | Moderate | Opportunistic infections | Infection | C. albicans, CMV | - | |
| 6 | Alveoler hemorrhage | + | Moderate | Alveoler hemorrhage | Alveoler hemorrhage | - | ||
| 7 | Respiratory failure | - | Moderate | Aspiration | Infection | Non-albicans Candida | + | >48 |
| 8 | Pneumonia | + | Severe | Alveoler hemorrhage | Alveoler hemorrhage | CMV | + | 8–24 |
| 9 | Respiratory failure | - | Moderate | Aspiration | Infection | CMV, Aspergillus spp., C. albicans | + | >48 |
| 10 | Pneumonia | - | Moderate | Malignancy | Infection | K. pneumoniae, CMV | - | |
| 11 | Pneumonia | - | Mild | Malignancy | Infection | C. albicans | + | 8–24 |
| 12 | Pneumonia | + | Moderate | Opportunistic infections | Infection | CMV, PcP | + | <8 |
| 13 | Pneumonia | - | Severe | Opportunistic infections | Infection | CMV, C. albicans | - | |
| 14 | Pneumonia | - | Severe | Aspiration | Infection | C. albicans | + | 8–24 |
| 15 | Alveoler hemorrhage | + | Moderate | Alveolar hemorrhage | Infection | C. albicans | - | |
| 16 | Respiratory failure | + | Moderate | Opportunistic infections | Infection | CMV, PcP | + | <8 |
| 17 | Pneumonia | + | Moderate | Opportunistic infections | Alveoler hemorrhage | - | ||
| 18 | Respiratory failure | + | Mild | Opportunistic infections | Infection | C. albicans | + | 24–48 |
| 19 | Pneumonia | + | Moderate | Opportunistic infections | Malignancy Infection | P. aeruginosa | + | 8–24 |
| 20 | Respiratory failure | + | Severe | Opportunistic infections | Infection | C. albicans, Respiratory viruses | - | |
| 21 | Pneumonia | - | Moderate | Aspiration | - | + | 8–24 | |
| 22 | Alveoler hemorrhage | + | Severe | Alveoler hemorrhage | Alveoler hemorrhage | - | ||
| 23 | Pneumonia | + | Severe | Multiple etiologiesa | Infection | Acremonium, CMV | + | <8 |
| 24 | Pneumonia | + | Moderate | Multiple etiologiesb | Infection | C. albicans, Respiratory viruses, CMV | + | >48 |
| 25 | Pneumonia | + | Severe | Multiple etiologiesc | Infection | Acremonium, Aspergillus spp., Respiratory viruses, CMV | + | >48 |
| 26 | Pneumonia | + | Moderate | Opportunistic infections | Infection | C. albicans | + | 8–24 |
| 27 | Pneumonia | + | Severe | Multiple etiologiesd | Malignancy | + | >48 | |
| 28 | Pneumonia | + | Moderate | Opportunistic infections | Infection | M. tuberculosis | + | >48 |
Abbrevations: CMV cytomegalovirus, PcP Pneumocystis jiroveci pneumonia
aOpportunistc infections, exacerbation of idiopathic pulmonary fibrosis
bMalignancy, alveoler hemorrhage, opportunistic infections, drug induced pulmonary toxicity
cPulmonary involvement of rheumatoid arthritis, opportunistic infections, drug induced pulmonary toxicity
dOpportunistc infections, malignancy